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Infection represents the presence of an inflammatory response and tissue injury due to the interaction of the
host with multiplying bacteria. The disease spectrum is a consequence of the variability in these interactions.
Diabetes, because of its effects on the vascular, neurological, and immune systems, can compromise the local
and systemic response to infection, potentially masking the typical clinical features and hindering diagnosis.
The early recognition of infection, particularly osteomyelitis, is paramount in the management of diabetic
foot disease. Careful clinical appraisal remains the cornerstone of the assessment. Hematologic, biochemical,
and radiological investigations are important aids in assessing the severity of infection. Microbiological as-
sessment, particularly in more severe infection, requires good-quality samples, combined with rapid transport
in an appropriate medium and effective communication with the laboratory. A focused, systematic approach
to the accurate diagnosis and treatment of infection, combined with careful monitoring, ensures the main-
tenance of optimal management.
Foot infection in diabetic patients can accelerate dra-
matically with devastating consequences if appropriate
treatment is not given promptly. The role of the health
professional caring for these individuals is to identify
and treat infection as early as possible, along with pre-
venting further episodes. However, diagnosing infection
in an ulcerated diabetic foot is not always straightfor-
ward. In diabetics, the host inflammatory response to
injury or infection may be reduced because of impaired
leukocyte function, vascular disease, and neuropathy
[1]. Thus, the classical signs of dolor, rubor, calor, and
tumor associated with infection may be absent. Further
confusing the issue are the effects of diabetic peripheral
neuropathy, which can mimic some of these findings.
When clinical signs are misleading, we rely on labo-
ratory tests to help us diagnose infection. However,
blood tests whose results can suggest infection (i.e.,
elevations in leukocyte count and erythrocyte sedi-
mentation rate) often yield falsely normal results. Also,
in the presence of chronic wounds, microbiological re-
sults may be difficult to interpret. Herein we examine
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definitions related to infection and describe, from our
clinical experience, how we diagnose infection in the
ulcerated diabetic foot.
DEFINING INFECTION IN
THE DIABETIC FOOT
There are many definitions of infection. It is most fre-
quently described as a disease caused by a microbial
pathogen that occurs when the presence of replicating
organisms is associated with tissue damage. The Amer-
ican College of Surgeons [2] defined infection as the
product of the entrance, growth, metabolic activities,
and resultant pathophysiological effects of microorgan-
isms in the tissues of the patient. More specifically,
White et al. [3] defined infection as the presence of
multiplying bacteria in body tissues, resulting in spread-
ing cellular injury due to competitive metabolism, tox-
ins, intracellular replication, or antigen-antibody re-
sponse (host reaction).
In some situations, such as when established path-
ogens are isolated from properly obtained specimens
of normally sterile fluid or tissues, diagnosing infection
is easy. The presence of microorganisms in a wound,
however, does not in itself define a clinical infection.
It is important to recognize that there is a spectrum,
or continuum, of disease (figure 1). All wounds are
exposed to skin commensals, and their microflora will
 at Acquisitions on Septem
ber 12, 2011
cid.oxfordjournals.org
D
ow
nloaded from
 
S84 • CID 2004:39 (Suppl 2) • Williams et al.
Figure 1. Spectrum of relationships between bacteria and wounds
Figure 2. Interactions of factors in infection
represent the surrounding environment. These contaminating
microbes can quickly become established within a wound,
reaching a state of colonization. Colonization is defined as the
presence of multiplying bacteria with no overt host immu-
nologic reaction [4]. Diabetic foot ulcers are commonly col-
onized with multiple species of organisms [5] that do not nor-
mally interfere with healing. Multiplication of bacteria within
the wound can reach a stage of “critical colonization” [6], in
which the host defenses are unable to maintain a balance, thus
resulting in delayed healing. Infection results when the invading
organisms overwhelm the host defenses, either by their sheer
numbers or by impairing the host’s immunity.
Infection confined to an ulcer bed can be described as local
infection. This is typically manifest as purulent secretions, often
accompanied by inflammatory signs. Untreated, local infection
can progress to involve the surrounding and deeper tissues.
Superficial soft tissue infection may be accompanied by painful
spreading erythema, known as cellulitis. Superficial infections
involve the skin but do not extend to fascia, muscle, tendon,
bone, or joint, as defined by the International Consensus on
the Diabetic Foot. Deep infections are those with evidence of
abscess, septic arthritis, osteomyelitis, or septic tenosynovitis.
The International Consensus on the Diabetic Foot distinguishes
bone infections as osteitis, infection of the cortical bone only,
and osteomyelitis, in which the bone marrow is involved.
Mechanisms of infection. Although microorganisms are
responsible for infection, there is debate as to the exact mech-
anisms by which they cause their adverse consequences and
their effect on a nonhealing chronic wound. Several factors are
thought to be involved (figure 2), including the bacterial bur-
den, or load, within a wound. Many authors have reported
healing to be delayed in a variety of wounds by an excessive
bacterial burden, and the likelihood of infection rises as the
bacterial burden increases [7]. Controversy persists over
whether the mere presence of a high bacterial bioburden war-
rants antimicrobial therapy [8]. Some have proposed that a
burden of 1105 cfu of bacteria per gram of tissue is required
to cause wound infection [7]. However, particularly virulent
organisms, such as b-hemolytic streptococci, secrete toxins that
allow rapid spread through the host’s tissue planes and are
capable of producing clinical infection at a lower burden.
As demonstrated by b-hemolytic streptococci, the virulence
of the colonizing microorganism correlates with the likelihood
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of infection. The significance of other individual species of
bacteria in a wound is not yet known. In uninfected diabetic
foot ulcers, the microflora is likely to be polymicrobial [5].
Staphylococcus species are the most frequently isolated organ-
isms, along with Streptococcus species, Pseudomonas aeruginosa,
and various coliform bacteria [9]. When infection ensues, es-
pecially in patients who have not recently received antibiotics,
aerobic gram-positive cocci are the dominant pathogens [10].
With careful sampling and culturing techniques, some anaer-
obic bacteria can also be recovered in 74%–95% of more severe
diabetic foot infections [11, 12]. A culture with polymicrobial
flora from a diabetic foot ulcer does not reveal which micro-
organisms are pathogens. In fact, bacteria are thought to be
synergistic and form biofilms on the surface of chronic wounds.
This allows anaerobes to survive on wound surfaces and sup-
ports growth of bacteria not normally considered pathogenic
[13].
The final factor potentially influencing the manifestation of
clinical infection is the host response. In diabetic patients, hy-
perglycemia reduces the activity of neutrophils and macro-
phages, the cells responsible for phagocytosis of bacteria and
foreign material in the initial inflammatory phase of healing
[14]. Ischemia, edema, and neuropathy reduce the capillary
vasodilation response to injury, further impairing the host’s
response to infection. Thus, the interaction between the bacteria
present within the wound and the host response determines
whether a wound will progress from colonization to infection
and how infection will manifest.
DIAGNOSING INFECTION IN
THE DIABETIC FOOT
In diabetic foot disease, we should aim to diagnose infection
at an early stage before it progresses toward deep infection and
damage to underlying tissue. Obtaining a rapid and accurate
diagnosis is, however, compounded by several factors. Because
the clinical signs of infection and microbiological analysis may
be misleading, it is important to combine all information avail-
able and not rely on any single laboratory report. Sometimes
subtle findings, such as failure of a wound to heal within the
expected time frame, may suggest infection.
Microbiological sampling. Traditional methods of sam-
pling to determine the causative agents of a wound infection
include rubbing the wound surface with a cotton swab, aspi-
rating purulent secretions, and obtaining tissue by curettage or
biopsy. Surface swabbing will collect skin contaminants, which
may or may not be pathogenic. Furthermore, routine process-
ing of swabs in clinical microbiology laboratories is rarely suf-
ficient to isolate anaerobic or fastidious bacteria; this results
both from the inadequate collection and/or transport method
and variations in laboratory processing and incubation [15, 16].
Culture of aspirated fluid or pus is more likely to reveal the
pathogenic organism, especially if taken from a deep pocket
within the wound. Culture of debrided infected tissue is an
excellent method for diagnosis in diabetic foot ulcers [17].
Removing superficial debris before sampling will eliminate sur-
face contaminants and provide more specific results. Tissue
biopsy is generally regarded as the reference standard for di-
agnosing infection [18]. Quantitative analysis of the deep tissue
can identify heavily inoculated wounds (1105 cfu/g of tissue),
but the clinical significance of this finding is unclear, because
it requires expertise in obtaining the sample and specialist lab-
oratory processing. If osteomyelitis is suspected, a specimen of
bone obtained at surgery or by percutaneous biopsy is the most
useful sample for culture. Although culture and histological
examination of a specimen is the most accurate method for
diagnosing infection, it not always easily obtainable. The tech-
nique used to obtain a microbiological sample is crucial. Al-
though some methods are clearly superior, those selected some-
times depend on local clinical and laboratory expertise.
Hematologic and biochemical markers. Blood tests, such
as WBC count, erythrocyte sedimentation rate, and C-reactive
protein level, are commonly requested to aid diagnosis. How-
ever, they are neither sensitive nor specific and are unlikely to
be elevated in local or superficial infection. Up to 50% of pa-
tients with a deep foot infection will not have leukocytosis [19,
20]; therefore, normal results do not preclude infection. In-
flammatory blood markers are simple and relatively inexpensive
to detect and may help guide the clinician in assessing treatment
responses in severe infection, when used in combination with
other factors. The erythrocyte sedimentation rate is frequently
used to monitor the response to treatment for osteomyelitis.
C-reactive protein levels have been demonstrated to be elevated
in diabetic foot ulceration, and other acute-phase proteins, such
as ferritin, a1-antitrypsin, and haptoglobulins, are currently un-
der investigation [21]. Blood glucose and hemoglobin A1c levels
may rise in infection.
Radiological diagnosis of osteomyelitis. Many imaging
techniques have been used to confirm or refute the presence
of bone infection. Plain radiographs are useful as an initial
evaluation and can be used as comparisons for later assess-
ments. Radiography can also detect gas in soft tissues, which
may represent severe soft tissue infection by anaerobic organ-
isms and possible abscess formation. Osteolytic bone changes
or periosteal elevation are suggestive of osteomyelitis. However,
these changes may not be present in the first few weeks of
infection, and their absence does not exclude osteomyelitis.
Follow-up radiography is usually done 2–6 weeks later, al-
though there is no agreed best interval. If the diagnosis remains
in doubt, further investigations may include an isotope bone
scan or labeled WBC scan, infrared thermography, ultrasound,
or MRI. Among these, MRI has been found to be more sensitive
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and far more specific than bone scans for diagnosis of osteo-
myelitis in diabetic feet [22, 23].
Clinical diagnosis of infection. The most important di-
agnostic tool for infection is bedside clinical evaluation. The
patient should be asked about an increase in pain, odor, or
exudate. Local infection of an ulcer can be difficult for inex-
perienced clinicians to recognize. Cutting and Harding [24]
described signs of infection in a granulating wound: delayed
healing, friable tissue, offensive odor, secretion of pus, increase
in lesion size, pain or discomfort, and prolonged exudate pro-
duction. Although symptoms may be absent in the neuropathic
foot, the clinical signs of abnormal granulation tissue, such as
a change in color from bright red to dark red, brown, or gray
and increased fragility and contact bleeding, should alert the
clinician to the possibility of infection. Spreading superficial
infection, usually represented by warmth, erythema, and edema,
may be less obvious in the diabetic foot. Systemic signs, such
as pyrexia, chills, and lymphadenopathy, are usually absent.
Even if infection is present, it can be difficult to differentiate
from acute neuro-osteoarthropathy (Charcot’s foot). Radio-
logical and clinical assessments, together with laboratory tests,
should aid differentiation of infectious from noninfectious bone
lesions.
If bone is visibly exposed within the wound, or can be de-
tected on gentle probing with a sterile instrument, osteomyelitis
is likely. In a study of 75 patients with 76 ulcers, osteomyelitis
was confirmed in 50 ulcers (66%) [25]. Thirty-three of these
ulcers had bone detectable on probing, whereas 4 with under-
lying osteomyelitis did not, giving a sensitivity of 66%, a spec-
ificity of 85%, and a positive predictive value of 89%. Other
deep structures exposed within the wound, such as tendon or
joint capsule, also signify deep infection. Probing a wound can
also detect foreign bodies and sinus tracts. It is essential that
a wound is carefully probed with a narrow, blunt instrument
able to convey to the user the presence of hard material within
the wound. It is among the quickest and easiest procedures to
do when evaluating a diabetic foot ulcer, and among the most
important.
CONCLUSION
To accurately diagnose infection, a combination of clinical, lab-
oratory, and imaging investigations must be used. Various stud-
ies have defined the proper techniques for obtaining and the
values of various tests. Determining which diagnostic proce-
dures to order depends somewhat on local expertise and avail-
ability. Among the simplest and most important of tests is
probing the debrided wound at the base of an ulcer; this should
be done on every wound to evaluate its depth and exclude
osteomyelitis. If in doubt, it is better to treat potential infection
empirically while waiting for a definitive diagnosis than to delay
treatment.
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